References

  1. https://adisinsight.springer.com/
  2. https://www.marketscreener.com/quote/stock/AKESO-INC-111325370/news/Akeso-Inc-Reports-Earnings-Results-for-the-Full-Year-Ended-December-31-2024-49477846/
  3. https://www.perplexity.ai/finance/9926.HK
  4. https://companiesmarketcap.com/inr/akeso/revenue/
  5. https://www.akesobio.com/en/media/akeso-news/230830/
  6. https://www.prnewswire.com/news-releases/akeso-inc-published-2023-interim-results-positive-profit-alert-301888961.html#:~:text=In%20respect%20of%20the%20Company's,excellent%20clinical%20value%20of%20cadonilimab.
  7. https://in.marketscreener.com/quote/stock/AKESO-INC-111325370/news/Akeso-Inc-Provides-Consolidated-Earnings-Guidance-for-the-Year-Ended-December-31-2023-46135567/#:~:text=In%20respect%20of%20the%20Company's,%C2%A9%20S&P%20Capital%20IQ%20%2D%202024
  8. https://www.akesobio.com/en/media/akeso-news/250331/#:~:text=On%20the%20commercial%20front%2C%20Akeso's,225%20million%20RMB%20in%202024.
  9. https://www.tipranks.com/news/company-announcements/akeso-inc-reports-significant-revenue-decline-for-2024
  10. https://www.statnews.com/2025/04/25/akeso-wins-chinese-approval-for-cancer-drug-ivonescimab-keytruda-rival/
  11. https://www.akesobio.com/en/rd-and-science/pipelines/
  12. https://www.3sbio.com/mobile/en/news/details.aspx?id=306
  13. https://www.expresspharma.in/pfizer-enters-into-an-exclusive-licensing-agreement-with-3sbio/#:~:text=Pfizer%20announced%20it%20has%20entered%20into%20an,a%20bispecific%20antibody%20targeting%20PD%2D1%20and%20VEGF.&text=3SBio%20plans%20to%20initiate%20the%20first%20Phase%203%20study%20in%20China%20in%202025.
  14. https://pharma.economictimes.indiatimes.com/news/pharma-industry/pfizer-signs-licensing-deal-worth-about-6-billion-with-chinas-3sbio-for-cancer-drug/121279748#:~:text=Bengaluru:%20U.S.%20drugmaker%20Pfizer%20said,happen%20in%20the%20third%20quarter.
  15. https://medicaldialogues.in/news/industry/pharma/pfizer-strikes-cancer-drug-deal-with-chinas-3sbio-148571
  16. https://finance.yahoo.com/news/pfizer-signs-6-billion-licensing-003547040.html?guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAIeyTDKUk5iS_xrYc0CXmkswiG982QUbl1E_NCgI2liLfYoqJj_hIGCvldn-uuxz7mD2t7V68K6gsZYYR2r5tY1vpPowEm1pyFTObFA9EC-VHWEK_h2jxaQhzrEpqnYIjPrB90-MeGsdq7aP_jRPeB3w7q5mI4sxEN1io1fIub9u&guccounter=2
  17. https://www.3sbio.com/ImgUpload/files/202503/2025032508152236587.pdf
  18. https://www.3sbio.com/mobile/en/news/details.aspx?id=306
  19. https://www.3sbio.com/en/science/index.aspx
  20. https://www.prnewswire.com/news-releases/insilico-medicine-secures-110-million-series-e-financing-to-advance-ai-driven-drug-discovery-innovation-302401040.html
  21. https://www.genengnews.com/topics/artificial-intelligence/insilico-moves-hq-to-cambridge-ma-completes-ipf-trial-enrollment/#:~:text=The%20company%20applied%20for%20a,the%20company%20generated%20in%202022.
  22. https://wewillcure.com/insights/ai-and-machine-learning/insilico-inks-exclusive-license-for-anti-cancer-molecule
  23. https://trial.medpath.com/news/37de6abd0de7af82/insilico-medicine-secures-110m-series-e-funding-achieves-unicorn-status-for-ai-driven-drug-discovery
  24. https://wewillcure.com/insights/ai-and-machine-learning/insilico-inks-exclusive-license-for-anti-cancer-molecule
  25. https://www.prnewswire.com/news-releases/insilico-medicine-secures-110-million-series-e-financing-to-advance-ai-driven-drug-discovery-innovation-302401040.html
  26. https://www.bio-itworld.com/news/2025/06/17/insilico-medicine-completes-oversubscribed-series-e-bringing-total-funding-to-$123-million
  27. https://insilico.com/
  28. https://wewillcure.com/insights/ai-and-machine-learning/insilico-inks-exclusive-license-for-anti-cancer-molecule
  29. https://www.prnewswire.com/news-releases/insilico-medicine-secures-110-million-series-e-financing-to-advance-ai-driven-drug-discovery-innovation-302401040.html
  30. https://www.bio-itworld.com/news/2025/06/17/insilico-medicine-completes-oversubscribed-series-e-bringing-total-funding-to-$123-million
  31. https://trial.medpath.com/news/37de6abd0de7af82/insilico-medicine-secures-110m-series-e-funding-achieves-unicorn-status-for-ai-driven-drug-discovery
  32. https://www.reuters.com/business/healthcare-pharmaceuticals/china-pharma-projects-disrupted-by-sino-us-tensions-2025-06-17/
  33. https://edition.cnn.com/2025/02/25/business/china-biotech-global-disruption-intl-hnk/index.html
  34. https://brandfinance.com/press-releases/sinopharm-is-the-worlds-fourth-strongest-pharma-brand-for-2025
  35. https://companiesmarketcap.com/inr/sinopharm/revenue/
  36. http://en.sinopharm.com/2023-12/05/c_18807.htm
  37. https://media-sinopharm.todayir.com/20240426165602329811180658_en.pdf#:~:text=The%20Group%20is%20mainly%20engaged%20in%20pharmaceutical%20products%20and%20medical%20device%20distribution%20business.&text=Besides%2C%20the%20Group%20is%20also%20engaged%20in,the%20synergistic%20development%20of%20its%20diversified%20businesses.
  38. https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0324/2025032400005.pdf
  39. http://ir.sinopharmgroup.com.cn/html/gov_boardreport.php
  40. https://www.tipranks.com/news/company-announcements/sinopharm-accord-reports-significant-profit-decline-in-2024-2
  41. https://www.tipranks.com/news/company-announcements/sinopharm-group-reports-challenging-2024-financial-results
  42. https://media-sinopharm.todayir.com/20240426165602329811180658_en.pdf#:~:text=The%20Group%20is%20mainly%20engaged%20in%20pharmaceutical%20products%20and%20medical%20device%20distribution%20business.&text=Besides%2C%20the%20Group%20is%20also%20engaged%20in,the%20synergistic%20development%20of%20its%20diversified%20businesses.
  43. https://www.tipranks.com/news/company-announcements/sinopharm-accord-reports-significant-profit-decline-in-2024-2
  44. https://www.smartkarma.com/home/newswire/earnings-alerts/sinopharm-group-co-ltd-h-1099-earnings-rise-by-2-8-in-q1-despite-revenue-decline/
  45. http://en.sinopharm.com/
  46. http://en.sinopharm.com/#:~:text=2025,More%20%3E%3E
  47. http://ir.sinopharmgroup.com.cn/html/index.php
  48. https://www.bajajbroking.in/blog/mankind-pharma-signs-licensing-pact-with-innovent-for-sintilimab
  49. https://www.business-standard.com/health/mankind-pharma-inks-pact-with-innovent-for-immunotherapy-drug-in-india-124122600938_1.html
  50. https://www.expresspharma.in/innovents-sycume-to-transform-thyroid-eye-disease-treatment-landscape-in-china-and-asia-globaldata/#:~:text=Share,and%20Treatment%20Guidelines%20for%20TED.
  51. https://companiesmarketcap.com/inr/innovent-biologics/revenue/
  52. https://companiesmarketcap.com/inr/innovent-biologics/revenue/
  53. https://www.innoventbio.com/ScienceAndProducts/Pipeline/Pipeline
  54. https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-akes.f/akeso/past#:~:text=Table_title:%20Earnings%20and%20Revenue%20History%20Table_content:%20header:,Free%20Cash%20Flow%20%7C%20:%20%2DCN%C2%A51.002b%20%7C
  55. https://in.marketscreener.com/news/akeso-inc-reports-earnings-results-for-the-half-year-ended-june-30-2025-ce7c50d9dd81f323#:~:text=Akeso%2C%20Inc.-,Reports%20Earnings%20Results%20for%20the%20Half%20Year%20Ended%20June%2030,%C2%A9%20S&P%20Capital%20IQ%20%2D%202025
  56. https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-first-half-2025-earnings-cn064-loss-per-share-vs-cn028
  57. https://stockanalysis.com/quote/hkg/1530/revenue/
  58. https://www.tipranks.com/news/company-announcements/3sbio-reports-increased-profits-despite-revenue-dip-in-h1-2025
  59. https://www.theglobeandmail.com/investing/markets/stocks/SHTDF/pressreleases/34299032/sinopharm-reports-mixed-financial-results-for-first-half-of-2025/
  60. https://companiesmarketcap.com/sinopharm/revenue/
  61. https://www.marketscreener.com/news/sinopharm-group-co-ltd-reports-earnings-results-for-the-half-year-ended-june-30-2025-ce7c50d8d980f526#:~:text=Sinopharm%20Group%20Co.-,Ltd.,Year%20Ended%20June%2030%2C%202025&text=04%20pm%20EDT-,Sinopharm%20Group%20Co.,CNY%201.19%20a%20year%20ago.
  62. https://www.tipranks.com/news/company-announcements/innovent-biologics-reports-strong-revenue-growth-and-profitability-in-h1-2025
  63. https://kr-asia.com/pulses/156979
  64. https://www.gurufocus.com/news/3081160/innovent-announces-2025-interim-results-and-business-updates-ivbiy-stock-news
  65. https://www.marketscreener.com/news/innovent-announces-2025-interim-results-and-business-updates-ce7c50deda8ff72c
  66. https://www.directorstalkinterviews.com/legend-biotech-corporation-legn-stock-analysis-exploring-a-115-potential-upside-in-the-biotech-sector/4121213502#:~:text=Legend%20Biotech%20Corporation%20(NASDAQ%3A%20LEGN,%25%2C%20according%20to%20analyst%20ratings.
  67. https://legendbiotech.com/
  68. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-fourth-quarter-and-full-year-2020/#:~:text=Financial%20Results%20for%20the%20Quarter,from%20product%20sales%20to%20date.
  69. https://www.sec.gov/Archives/edgar/data/1801198/000115752321000358/a52397619ex99_1.htm#:~:text=In%20December%202020%2C%20Legend%20Biotech,initiation%20of%20the%20BLA%20submission.
  70. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-fourth-quarter-and-full-year-2021/#:~:text=Financial%20Results%20for%20the%20Quarter,from%20product%20sales%20to%20date.
  71. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-third-quarter-2021-financial-results-and/
  72. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-full-year-2022-results-and-recent#:~:text=As%20of%20December%2031%2C%202022,%2C%20and%20short%2Dterm%20investments.&text=Revenue%20for%20the%20year%20ended,year%20ended%20December%2031%2C%202021%20.
  73. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-fourth-quarter-and-full-year-2023-results
  74. https://www.macrotrends.net/stocks/charts/LEGN/legend-biotech/revenue
  75. https://stockanalysis.com/stocks/legn/revenue/
  76. https://legendbiotech.com/research-development/pipeline/
  77. https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-solid-2025-interim-results/
  78. https://www.wuxibiologics.com/press-release/wuxi-biologics-ireland-facility-receives-ema-approval-for-commercial-manufacturing-of-innovative-biologic/
  79. https://www.prnewswire.com/news-releases/wuxi-biologics-reports-solid-2025-interim-results-302533431.html#:~:text=Dr.,biologic%20can%20be%20made'.%22&text=WuXi%20Biologics%20(stock%20code:%202269,including%2024%20in%20commercial%20manufacturing.
  80. https://www.pharmamanufacturing.com/industry-news/news/55311088/wuxi-biologics-reports-2025-growth-with-expanded-services-new-capacity
  81. https://www.prnewswire.com/news-releases/wuxi-biologics-achieves-cdmo-of-the-year-among-three-prestigious-imapac-awards-302554582.html#:~:text=The%20development%20cycle%20for%20its,the%20value%20we%20consistently%20deliver.
  82. https://www.wuxibiologics.com/news_media-press_release-2021_year-2021_03_23_2020_results_record_high_despite_a_challenging_year/
  83. https://stockanalysis.com/quote/otc/WXXWY/revenue/
  84. https://companiesmarketcap.com/wuxi-biologics/revenue/
  85. https://www.wuxibiologics.com/wuxi-biologics-achieved-record-growth-and-profitability-in-2021-banner-year-for-commercial-manufacturing/
  86. https://www.wuxibiologics.com/wp-content/uploads/respress-1.pdf
  87. https://www.wuxibiologics.com/wuxi-biologics-reports-remarkable-2022-annual-results/
  88. https://www.prnewswire.com/news-releases/wuxi-biologics-reports-strong-2022-interim-results-301607649.html#:~:text=The%20Group%20continued%20to%20advance,Group's%20next%20rapid%20growth%20engines.
  89. https://www.nasdaq.com/press-release/wuxi-biologics-reports-remarkable-2022-annual-results-2023-03-22
  90. https://companiesmarketcap.com/wuxi-biologics/revenue/
  91. https://medicalbuyer.co.in/wuxi-biologics-reports-2023-annual-results/#:~:text=The%20Group's%20revenue%20exceeded%20RMB17,reinforcing%20stable%20short%2Dterm%20growth.
  92. https://in.marketscreener.com/quote/stock/GSK-PLC-9590199/news/WuXi-Biologics-Reports-Solid-2023-Annual-Results-46299192/#:~:text=The%20'Win%2Dthe%2DMolecule,in%20the%20post%2DCOVID%20era.
  93. https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-solid-2024-annual-results-and-expects-accelerated-growth-in-2025/
  94. https://www.prnewswire.com/news-releases/wuxi-biologics-reports-solid-2024-annual-results-and-expects-accelerated-growth-in-2025-302410501.html#:~:text=Table_title:%20Share%20this%20article%20Table_content:%20header:%20%7C,:%207%2C650.8%20%7C%20:%2012.1%20%25%20%7C
  95. https://stockanalysis.com/quote/otc/WXXWY/
  96. https://companiesmarketcap.com/wuxi-biologics/earnings/
  97. https://in.marketscreener.com/news/wuxi-biologics-cayman-reports-solid-2025-interim-results-ce7c51dddb8bf422
  98. https://www.wuxibiologics.com/wp-content/uploads/int-3.pdf
  99. https://www.prnewswire.com/news-releases/wuxi-biologics-reports-solid-2025-interim-results-302533431.html#:~:text=The%20Group%20added%20a%20first,platform%20for%20high%20concentration%20biologics.
  100. https://www.wuxibiologics.com/
  101. https://www.wuxibiologics.com/wp-content/uploads/int-3.pdf
  102. https://firstwordpharma.com/story/5916424#:~:text=About%20Duality%20Biologics,MOA%20ADCs%20and%20autoimmune%20ADCs.
  103. https://sweden.dealroom.co/companies/duality_biologics#:~:text=DualityBio%20is%20a%20clinical%20stage,Investors
  104. https://www.pharmafocusasia.com/pressreleases/duality-biologics-announces-license-agreement-of-its-next-generation#:~:text=Strategic%20Collaboration%EF%BD%9CDuality%20Biologics%20Announces%20License%20Agreement%20of,pipeline%20of%20antibody%2Ddrug%20conjugates%20(ADCs)%20targeting%20cancers
  105. https://www.dualitybiologics.com/
  106. https://investors.biontech.de/news-releases/news-release-details/biontech-and-dualitybio-announce-phase-3-trial-adc-candidate/#:~:text=DualityBio%20is%20a%20clinical%2Dstage,ADCs%20and%20dual%20payload%20ADCs.
  107. https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-duality-biotherapeutics-shares-set-rise-91-hong-kong-debut-2025-04-15/#:~:text=Summary,June%202021%2C%20Dealogic%20data%20showed.
  108. https://pharma.economictimes.indiatimes.com/news/research-and-development/biontech-achieves-milestone-in-breast-cancer-drug-trial-with-duality-biologics/123728675#:~:text=BioNTech%2C%20Duality%20score%20initial%20trial,to%20participants%20in%20two%20groups.
  109. https://tc.dualitybiologics.com/upload/listedco/listconews/sehk/2025/0407/11615076/2025040700031_c.pdf
  110. https://www.reuters.com/markets/companies/9606.HK#:~:text=Table_title:%20Income%20Statement%20Table_content:%20header:%20%7C%20Millions,%7C%202024:%20%2D1050.434%20%7C%202023:%20%2D357.512%20%7C
  111. https://pitchbook.com/profiles/company/466595-65#stock
  112. https://pitchbook.com/profiles/company/466595-65#:~:text=Financials%20Summary,FY%202024%20725
  113. https://www.reuters.com/markets/companies/9606.HK#:~:text=Table_title:%20Income%20Statement%20Table_content:%20header:%20%7C%20Millions,%7C%202024:%20%2D1050.434%20%7C%202023:%20%2D357.512%20%7C
  114. https://en.dualitybiologics.com/news/584.html#:~:text=DualityBio%20(9606.HK)%20Officially,Embarking%20on%20a%20New%20Chapter&text=April%2015%2C%202024%20%E2%80%93%20DualityBio%20(,n(HK505%20million).
  115. https://www.prnewswire.com/news-releases/duality-biologics-completed-90-million-series-b-financing-301294736.html
  116. https://tracxn.com/d/companies/duality-biologics/__kuei0jUPh-2_6Qa_D3iKvUvtFxryToSOdmk8CXGlVKA
  117. https://www.futuremarketinsights.com/reports/biologics-market#:~:text=Biologics%20Market%20Size%20and%20Share,%2C%20Novartis%20AG%2C%20Pfizer%20Inc.
  118. https://investors.biontech.de/news-releases/news-release-details/biontech-announces-second-quarter-2025-financial-results-and/#:~:text=BNT324/DB%2D1311%20is%20an,showed%20encouraging%20preliminary%20clinical%20activity.
  119. https://en.dualitybiologics.com/upload/file/20250407/fc41e0a3170415c1fe7b8e91a2b369f9.pdf#:~:text=The%20Offer%20Price%20is%20expected%20to%20be,expected%20to%20be%20not%20less%20than%20HK$94.60.
  120. https://www.ainvest.com/news/china-sciwind-biosciences-global-glp-1-obesity-drug-race-deep-dive-competitive-positioning-growth-potential-2507/
  121. https://www.contractpharma.com/breaking-news/sciwind-biosciences-and-verdiva-bio-enter-global-licensing-agreement/#:~:text=Sciwind%20has%20granted%20Verdiva%20the,of%20key%20products%20like%20Ecnoglutide.
  122. https://www.sciwindbio.com/news-release-jun-12-25#:~:text=Sciwind%20news%20release%20June%2012,June%2020%20%E2%80%93%2023%2C%202025.
  123. https://www.denvergazette.com/2025/07/25/exclusive-chinas-sciwind-is-in-talks-to-license-weight-loss-drug-in-us-ceo-says-4a76ec36-d17e-5bb2-9c8a-6e8618722d5c/#:~:text=By%20Andrew%20Silver,Lancet%20Diabetes%20&%20Endocrinology%20in%20June.
  124. https://www.biopharmadive.com/news/verdiva-obesity-biotech-startup-launch-sciwind-china/736880/#:~:text=Verdiva%20Bio%2C%20which%20launched%20on,CR%20via%20Getty%20Images
  125. https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-sciwind-is-talks-license-weight-loss-drug-us-ceo-says-2025-07-25/#:~:text=Pricing%20in%20China%20would%20be,Silver;%20Editing%20by%20Kim%20Coghill
  126. https://www.biospectrumasia.com/news/48/17632/chinese-biopharma-startup-secures-series-b-funding-for-innovative-biologics.html#:~:text=The%20financing%20was%20led%20by,Capital%20and%20Haibang%20Venture%20Capital&text=Hangzhou%20Sciwind%20Biosciences%20Co.%2C%20Ltd,our%20pipeline%20into%20clinical%20development.%22
  127. https://www.geneonline.com/sciwind-biosciences-series-c/#:~:text=After%20a%20$37%20million%20Series%20B%20funding,target%20diabetes%2C%20obesity%2C%20and%20non%2Dalcoholic%20steatohepatitis%20(NASH).
  128. https://firstwordpharma.com/story/5417845#:~:text=HANGZHOU%2C%20China%20and%20SAN%20FRANCISCO,the%20first%20half%20of%202022.
  129. https://www.prnewswire.com/news-releases/sciwind-biosciences-secures-us37-million-series-b-financing-301230650.html
  130. https://www.crunchbase.com/funding_round/sciwind-biosciences-series-b--32965461
  131. https://tracxn.com/d/companies/sciwind/__HwKggjcaMLsvKvy5a-dPCEgrvA9WqozrFweFoI2htsg
  132. https://tracxn.com/d/companies/sciwind/__HwKggjcaMLsvKvy5a-dPCEgrvA9WqozrFweFoI2htsg
  133. https://www.sciwindbio.com/
  134. https://www.acnnewswire.com/press-release/english/102027/lepu-biopharma-(2157.hk)-announces-2025-interim-results#:~:text=The%20Company%20has%20developed%20multiple,recognition%20of%20the%20platform's%20value.
  135. https://en.lepubiopharma.com/upload/listedco/listconews/sehk/2025/0327/2025032700401.pdf
  136. https://www.jcnnewswire.com/pressrelease/102027/2/Lepu-Biopharma-(2157HK)-announces-2025-interim-results#:~:text=The%20Company%20will%20also%20explore,licensing%20agreements%2C%20or%20joint%20ventures.
  137. https://en.lepubiopharma.com/#:~:text=Their%20mission%20is%20to%20develop%20first%2Din%2Dclass%20and,oncolytic%20viruses%2C%20and%20others%20*%20**Manufacturing%20facilities**
  138. https://en.lepubiopharma.com/new/124.html#:~:text=Lepu%20Biopharma%20Team%20has%20mature,opportunities%20for%20subdividing%20the%20track.%20%22
  139. https://en.lepubiopharma.com/upload/2023-05/168311464056430300.pdf
  140. https://en.lepumedical.com/uploads/file/20250822/lepu-2025-semi-annual-report.pdf
  141. https://dcfmodeling.com/blogs/health/2291hk-financial-health?srsltid=AfmBOopGK0ruLY3du0fWpjCzlW4VcvDMx4u_atGKJFxo0bPBpqlS3YKR
  142. https://www.marketsmojo.com/stocks-analysis/financial-annual/lepu-biopharma-co--1289847-102
  143. https://en.caclp.com/industry-news/1571.html
  144. https://en.lepubiopharma.com/upload/listedco/listconews/sehk/2025/0327/2025032700401.pdf
  145. https://en.lepubiopharma.com/upload/listedco/listconews/sehk/2024/0821/2024082100594.pdf
  146. https://en.lepumedical.com/uploads/file/2022-annual-report.pdf
  147. https://uk.marketscreener.com/quote/stock/LEPU-BIOPHARMA-CO-LTD-133292522/company/#:~:text=Table_title:%20Sales%20by%20Activity:%20Lepu%20Biopharma%20Co.%2C,%7C%202020:%20368M%20%7C%202024:%20%2D%20%7C
  148. https://stockanalysis.com/quote/hkg/2157/revenue/
  149. https://dcfmodeling.com/blogs/health/2291hk-financial-health?srsltid=AfmBOopGK0ruLY3du0fWpjCzlW4VcvDMx4u_atGKJFxo0bPBpqlS3YKR
  150. https://en.lepubiopharma.com/upload/listedco/listconews/sehk/2025/0327/2025032700401.pdf
  151. https://www.nature.com/articles/d41573-025-00102-1#:~:text=Investment%20and%20industry%20growth,channels%20for%20pre%2Drevenue%20innovators.
  152. https://baipharm.chemlinked.com/news/chinas-pharmaceutical-industry-expected-to-be-the-worlds-largest-in-less-than-10-years#:~:text=The%20Chinese%20pharmaceutical%20market%20segments,%25)%20to%20overall%20pharmaceutical%20sales.
  153. https://www.parexel.com/application/files/resources/assets/EN_Corporate_Analysis_of_Major_Pharmaceutical_Markets_in_Asia-Pacific_Region_China_White_Paper.pdf
  154. https://www.privacyshield.gov/ps/article?id=China-Pharmaceuticals#:~:text=and%20trade%20data.-,Overview,2020%2C%20according%20to%20BMI%20Research.
  155. https://english.news.cn/20220510/0e7d15a56ee34a7c927fcf45b6830df8/c.html#:~:text=in%202021%2DXinhua-,China's%20pharmaceutical%20industry%20posts%20revenue%2C%20profit%20growth%20in%202021,a%20year%20ago%2C%20Zhou%20said.
  156. https://www.fortunebusinessinsights.com/impact-of-covid-19-on-pharmaceuticals-market-102685#:~:text=The%20market%20is%20projected%20to%20grow%20from,a%20market%20share%20of%2045.10%25%20in%202023.
  157. https://efpia.eu/media/2rxdkn43/the-pharmaceutical-industry-in-figures-2024.pdf
  158. https://www.efpia.eu/media/637143/the-pharmaceutical-industry-in-figures-2022.pdf
  159. https://www.ibisworld.com/china/industry/pharmaceutical-manufacturing/324/#:~:text=Pharmaceutical%20Manufacturing%20in%20China%20industry,%2C%20up%203.2%25%20from%202022.
  160. https://metroplastic.in/which-country-leads-the-world-in-pharmaceutical-production-insider-facts-industry-trends#:~:text=Table_title:%20The%20Giant:%20Which%20Country%20Dominates%20Pharmaceutical,$60B%20%7C%20Major%20Companies:%20Novartis%2C%20Roche%20%7C
  161. https://www.grandviewresearch.com/horizon/outlook/pharmaceutical-market/china#:~:text=China%20pharmaceutical%20market%20highlights,Other%20key%20industry%20trends
  162. https://www.drugpatentwatch.com/blog/the-dragon-awakes-charting-the-unstoppable-growth-of-chinese-pharmaceuticals-in-the-global-market/#:~:text=The%20narrative%20of%20Chinese%20pharma,recognition%20of%20its%20innovative%20assets.
  163. https://efpia.eu/media/2rxdkn43/the-pharmaceutical-industry-in-figures-2024.pdf#:~:text=There%20is%20rapid%20growth%20in%20the%20market,US%20market%20(source:%20IQVIA%20MIDAS%2C%20May%202024).
  164. https://www.statista.com/outlook/hmo/pharmaceuticals/china
  165. https://assets.kpmg.com/content/dam/kpmg/cn/pdf/en/2025/04/china-life-sciences-sector-overview-and-outlook.pdf
  166. https://www.hyperec.com/blog/what-country-is-best-for-pharmaceutical-jobs/
  167. https://www.akesobio.com/media/2297/2024-interim-corporate-deck.pdf?utm
  168. https://za.investing.com/news/company-news/calian-acquires-infield-scientific-to-expand-defence-capabilities-93CH-3905757
  169. https://www.akesobio.com/media/2656/akeso-2025-h1-english-final.pdf
  170. https://visiblealpha.com/data-snapshot/akeso-summit-slide-on-mixed-drug-trial-but-long-term-prospects-buoy-analysts/#:~:text=Chinese%20biotech%20group%20Akeso%20(HKG,to%20$1%20billion%20by%202034.
  171. https://www.mitrade.com/au/insights/news/live-news/article-8-1107847-20250909#:~:text=Summit%20licensed%20rights%20to%20sell,(not%20profits)%20it%20generates.
  172. https://trial.medpath.com/news/b64fb57f80bd3936/summit-therapeutics-future-prospects-and-investment-considerations
  173. https://www.nasdaq.com/articles/1-monster-stock-making-buy-and-hold#:~:text=What's%20more%2C%20ivonescimab%20could%20prove,next%20five%20to%2010%20years.
  174. https://www.statista.com/statistics/973523/top-drugs-by-year-on-year-sales-increase/
  175. https://www.biopharmadive.com/news/merck-keytruda-subcutaneous-cancer-sales-drug-delivery/801889/#:~:text=Delivered%20under%20the%20skin%20in,almost%20$32.7%20billion%20in%202026.
  176. https://www.accio.com/business/top-product-forecasts-for-2026#:~:text=Product%20Recommendations,intermediate%20for%20semi%2Dsynthetic%20cephalosporins.
  177. https://www.barrons.com/articles/keytruda-gardasil-sales-merck-stock-c19d0661
  178. https://www.biopharmadive.com/news/merck-keytruda-subcutaneous-cancer-sales-drug-delivery/801889/#:~:text=Delivered%20under%20the%20skin%20in,over%20$7%20billion%20by%202032.
  179. https://www.barrons.com/articles/keytruda-gardasil-sales-merck-stock-c19d0661
  180. https://www.fiercepharma.com/pharma/whos-no-1-2028-sales-evaluate-pegs-roche-photo-finish-and-mercks-keytruda-landslide
  181. https://www.drugdiscoverytrends.com/are-glp-1s-about-to-dethrone-oncology-as-pharmas-biggest-segment-not-for-a-few-years-yet/#:~:text=On%20the%20product%20level%2C%20according,from%20those%20two%20oncological%20therapies.
  182. https://www.nasdaq.com/articles/mercks-keytruda-dependency-growth-story-expiration-date#:~:text=There's%20no%20ambiguity%20about%20Keytruda's,That%20outcome%20looks%20increasingly%20likely.
  183. https://pubmed.ncbi.nlm.nih.gov/40057343/
  184. https://www.drugdiscoverytrends.com/2024s-blockbusters-top-50-pharmaceuticals-by-sales/#:~:text=In%202024%2C%20Merck's%20Keytruda%20continued,clouds%20its%20long%2Dterm%20dominance.
  185. https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=Generally%20Accepted%20Accounting%20Principles%20(GAAP,a%20collaboration%20with%20Daiichi%20Sankyo.
  186. https://www.smmttx.com/pressrelease/https-www-smmttx-com-wp-content-uploads-2025-08-2025_pr_0811-_-q2-2025-earnings-press-release-_-final-pdf/
  187. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-enters-exclusive-licensing-agreement-3sbio
  188. https://www.sec.gov/Archives/edgar/data/78003/000007800322000003/pfe-12312021xex99.htm#:~:text=prior%2Dyear%20quarter.-,%E2%96%AA,$135%20million%2C%20or%201%25.
  189. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-invests-43-billion-battle-cancer#:~:text=Today%2C%20Pfizer%20Oncology%20has%20an,early%2Dstage%20oncology%20clinical%20pipeline.
  190. https://www.businesswire.com/news/home/20240130420927/en/Pfizer-Reports-Full-Year-2023-Results-and-Reaffirms-Full-Year-2024-Financial-Guidance
  191. https://s206.q4cdn.com/795948973/files/doc_financials/2024/q4/Q4-2024-Earnings-Infographic-FINAL.pdf
  192. https://www.echemi.com/cms/2241569.html#:~:text=On%20February%204%2C%20Pfizer%20announced,in%20revenue%2C%20totaling%20$15.612%20billion
  193. https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.8543
  194. https://www.pharmexec.com/view/pfizer-3sbio-forge-licensing-pact-ssgj-707-target-lung-colorectal-gynecologic-cancers#:~:text=Efficacy%20Highlights%20from%20SSGJ%2D707,demonstrated%20an%20ORR%20of%2033.3%25.
  195. https://ascopubs.org/doi/pdf/10.1200/JCO.2025.43.16_suppl.8543#:~:text=SSGJ%2D707%2010mg/kg%20Q3W,Sunshine%20Pharmaceuticals%20CO.%2C%20Ltd.
  196. https://www.expresspharma.in/pfizer-completes-licensing-agreement-with-3sbio/#:~:text=SSGJ%2D707%20is%20currently%20undergoing,$150%20million%20in%20option%20payments.
  197. https://www.nasdaq.com/articles/pfizer-q2-earnings-beat-estimates-oncology-drives-top-line-growth#:~:text=PFE's%20Oncology%20Sales,rose%2048%25%20to%20$251%20million.
  198. https://www.tradingview.com/news/zacks:ab3fd8cd3094b:0-is-pfe-stock-a-buy-after-14-rise-post-drug-pricing-deal-with-trump/#:~:text=PFE's%20Other%20Headwinds%20in%202025,most%20affected%20by%20the%20IRA.
  199. https://in.investing.com/news/swot-analysis/pfizers-swot-analysis-stock-outlook-amid-patent-cliff-and-strategic-moves-93CH-5036334
  200. https://www.pharmexec.com/view/pfizer-3sbio-forge-licensing-pact-ssgj-707-target-lung-colorectal-gynecologic-cancers#:~:text=Under%20the%20terms%20of%20the,royalties%20on%20potential%20future%20sales.
  201. https://finance.yahoo.com/news/pfizer-3sbio-conclude-licensing-deal-115946751.html
  202. https://www.globenewswire.com/news-release/2025/10/09/3164300/0/en/GenAI-in-MedTech-Market-Trends-Applications-and-Growth-Opportunities.html
  203. https://finance.yahoo.com/news/generative-ai-healthcare-market-hit-144000040.html
  204. https://finance.yahoo.com/news/generative-ai-healthcare-market-hit-144000040.html
  205. https://www.sciencedirect.com/science/article/pii/S135964462400117X#:~:text=DL%20uncovers%20intricate%20relationships%20between,in%20medicinal%20chemistry%20remains%20nascent.
  206. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1331062/full
  207. https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality
  208. https://brandfinance.com/press-releases/sinopharm-is-the-worlds-fourth-strongest-pharma-brand-for-2025
  209. http://en.sinopharm.com/#:~:text=war%2Dtorn%20China-,2025,boosts%20China%2DGuyana%20medical%20cooperation
  210. http://en.sinopharm.com/2025-07/24/c_20211.htm
  211. http://en.sinopharm.com/2025-07/11/c_20201.htm
  212. http://en.sinopharm.com/2025-05/23/c_20115.htm#:~:text=Contact%20Us-,Sinopharm%2C%20Lonza%20extend%20Suzhou%20Capsugel%20joint%20venture%20for%2020%20years,Photo/sinopharm.com%5D
  213. http://en.sinopharm.com/2025-05/23/c_20115.htm
  214. http://en.sinopharm.com/2025-08/21/c_20247.htm
  215. https://www.tipranks.com/news/company-announcements/sinopharm-reports-mixed-financial-results-for-first-half-of-2025
  216. https://www.cancer.gov/about-cancer/treatment/research/car-t-cells
  217. https://my.clevelandclinic.org/health/treatments/17726-car-t-cell-therapy
  218. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/car-t-cell.html#:~:text=Collecting%20the%20T%20cells,until%20enough%20cells%20are%20collected.
  219. https://finance.yahoo.com/news/car-t-cell-therapy-market-150000466.html
  220. https://www.genengnews.com/topics/bioprocessing/top-10-contract-development-and-manufacturing-organizations-2025/#:~:text=1.,%E2%80%9Capproaching%2030%25%E2%80%9D).
  221. https://pmc.ncbi.nlm.nih.gov/articles/PMC10660735/#:~:text=The%20market%20is%20poised%20for,billion%20between%202024%20and%202029.
  222. https://www.biochempeg.com/article/329.html#:~:text=Release%20date%EF%BC%9A2023/2/,drugs%20are%20nearly%20$7%20billion.
  223. https://www.biochempeg.com/article/389.html#:~:text=Antibody%E2%80%93drug%20conjugates%20(ADCs),Zynlonta
  224. https://my.clevelandclinic.org/health/treatments/antibody-drug-conjugates
  225. https://www.biochempeg.com/article/389.html#:~:text=Antibody%E2%80%93drug%20conjugates%20(ADCs),Zynlonta
  226. https://sg.finance.yahoo.com/news/global-antibody-drug-conjugates-adc-125100425.html
  227. https://www.acnnewswire.com/press-release/english/102027/lepu-biopharma-(2157.hk)-announces-2025-interim-results#:~:text=The%20Company%20has%20developed%20multiple,recognition%20of%20the%20platform's%20value.
  228. https://www.sinobiopharm.com/en/news-center/dynamic/24260.html
  229. http://ir.sinopharmgroup.com.cn/html/about.php
  230. https://trial.medpath.com/news/af18f9a232f67a5c/sino-biopharm-reports-strong-h1-2025-results-with-27-growth-in-innovative-drug-sales-and-strategic-lanova-acquisition?utm_source=chatgpt.com
  231. https://www.businessnewsasia.com/2025081852393223-sino-biopharm-1177-hk-announces-2025-interim-results/?utm_source=chatgpt.com
  232. https://www.businessnewsasia.com/2025081852393223-sino-biopharm-1177-hk-announces-2025-interim-results/?utm_source=chatgpt.com
  233. http://en.sinopharm.com/
  234. https://media-sinopharm.todayir.com/202508250934011727103959_en.pdf
  235. https://www.takeda.com/newsroom/newsreleases/2025/innovent/

Pharma Insight Reports

https://adisinsight.springer.com/insight-hub